Literature DB >> 16844353

Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi.

Miriam Rolón1, Elena M Seco, Celeste Vega, Juan J Nogal, José A Escario, Alicia Gómez-Barrio, Francisco Malpartida.   

Abstract

The growth inhibitory effects on Trypanosoma cruzi of several natural tetraene macrolides and their derivatives were studied and compared with that of amphotericin B. All tetraenes strongly inhibited in vitro multiplication. Proliferation of epimastigotes was arrested by all these drugs at < or =3.6 microM, which were also active on amastigotes proliferating in fibroblasts. Compared with amphotericin B, the compounds were less effective but also less toxic, showing no effect on the proliferation of J774 and NCTC 929 mammalian cells at concentrations active against the parasites. CE-108B (a polyene amide) appeared to be an especially potent trypanocidal compound, with strong in vivo trypanocidal activity and very low or no toxic side effects, and thus should be considered for further studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844353     DOI: 10.1016/j.ijantimicag.2006.02.025

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  11 in total

Review 1.  Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.

Authors:  Cristina Fonseca-Berzal; Vicente J Arán; José A Escario; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2018-09-19       Impact factor: 2.289

2.  In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi.

Authors:  Juliana Saraiva; Celeste Vega; Mirian Rolon; Rosangela da Silva; Márcio Luis Andrade E Silva; Paulo Marcos Donate; Jairo Kenupp Bastos; Alícia Gomez-Barrio; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2006-10-12       Impact factor: 2.289

3.  Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles.

Authors:  Cristina Fonseca-Berzal; José Antonio Escario; Vicente J Arán; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2014-01-17       Impact factor: 2.289

4.  Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.

Authors:  Sabrina Cencig; Nicolas Coltel; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

5.  Liposomal formulation of turmerone-rich hexane fractions from Curcuma longa enhances their antileishmanial activity.

Authors:  Ana Claudia F Amaral; Luciana A Gomes; Jefferson Rocha de A Silva; José Luiz P Ferreira; Aline de S Ramos; Maria do Socorro S Rosa; Alane B Vermelho; Igor A Rodrigues
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

Review 6.  Biotechnological production and application of the antibiotic pimaricin: biosynthesis and its regulation.

Authors:  Jesús F Aparicio; Eva G Barreales; Tamara D Payero; Cláudia M Vicente; Antonio de Pedro; Javier Santos-Aberturas
Journal:  Appl Microbiol Biotechnol       Date:  2015-10-29       Impact factor: 4.813

7.  Antiprotozoal Activity of Triazole Derivatives of Dehydroabietic Acid and Oleanolic Acid.

Authors:  Mariano Walter Pertino; Celeste Vega; Miriam Rolón; Cathia Coronel; Antonieta Rojas de Arias; Guillermo Schmeda-Hirschmann
Journal:  Molecules       Date:  2017-02-28       Impact factor: 4.411

8.  Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage.

Authors:  Carolina Aquilino; Maria Luisa Gonzalez Rubio; Elena Maria Seco; Leticia Escudero; Laura Corvo; Manuel Soto; Manuel Fresno; Francisco Malpartida; Pedro Bonay
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

9.  Antiparasitic Activity and Essential Oil Chemical Analysis of the Piper Tuberculatum Jacq Fruit.

Authors:  Valterlúcio Dos Santos Sales; Álefe Brito Monteiro; Gyllyandeson de Araújo Delmondes; Emmily Petícia do Nascimento; Francisco Rodolpho Sobreira Dantas Nóbrega de Figuêiredo; Cristina Kelly de Souza Rodrigues; Josefa Fernanda Evangelista de Lacerda; Cícera Norma Fernandes; Maysa de Oliveira Barbosa; Adamo Xenofonte Brasil; Saulo Relison Tintino; Maria Celeste Vega Gomez; Cathia Coronel; Henrique Douglas Melo Coutinho; José Galberto Martins da Costa; Cícero Francisco Bezerra Felipe; Irwin Rose Alencar de Menezes; Marta Regina Kerntopf
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 10.  Advances in nanocarriers as drug delivery systems in Chagas disease.

Authors:  Christian Quijia Quezada; Clênia S Azevedo; Sébastien Charneau; Jaime M Santana; Marlus Chorilli; Marcella B Carneiro; Izabela Marques Dourado Bastos
Journal:  Int J Nanomedicine       Date:  2019-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.